Pharmafile Logo

Warner Chilcott

- PMLiVE

Valeant sweetens Allergan offer with help from Nestle deal

Will divest skincare treatments to sidestep product conflict issues

- PMLiVE

Battle lines drawn as Allergan rejects Valeant offer

Turns down $47bn takeover bid saying it undervalues the company

- PMLiVE

Allergan resists Valeant’s advances

Threatens to derail proposed $45bn merger

- PMLiVE

Valeant offers $45.7bn for Botox firm Allergan

Trend for major pharma deals continues

- PMLiVE

Interview: Julia Kendrick

Allergan's in-house PR counsel on winning Communiqué 2013's Young Achiever

- PMLiVE

Restasis commercial among most memorable ads of 2013

TV spot for Allergan’s eye drug among top 10 in Nielsen ratings

- PMLiVE

ABPI reprimands for four pharma firms

Allergan, Shire Pharmaceuticals, Gedeon Richter and Sanofi breach Code of Practice

- PMLiVE

Allergan’s Julia Kendrick recognised as Young Achiever

Stood out in a hotly contested category at the Communiqué Awards 2013

- PMLiVE

Allergan veteran joins Kala as head of business development

Charles McDermott has experience in ophthalmology

- PMLiVE

Actavis to buy Warner Chilcott in $8.5bn deal

Combined company will have annual revenues of about $11bn

- PMLiVE

Actavis in talks to buy Warner Chilcott

Companies confirm preliminary discussions have taken place

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links